Matches in SemOpenAlex for { <https://semopenalex.org/work/W2947257837> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W2947257837 abstract "550 Background: We have previously demonstrated that PD-L1 mRNA expression can serve as prognostic biomarker in breast cancer (BC). In ER+/HER2- BC, RS and 70-gene signature are used to predict the risk of recurrence and benefit from chemotherapy. Methods: Discovery cohort (cohort 1) included 302 patients diagnosed with primary ER+/HER2- BC (1997-2005) in Stockholm health care region. Gene expression profiling has been performed using DNA microarrays (GSE48091) while information regarding tumor characteristics, treatment and follow-up have been obtained. TCGA’s dataset including 590 ER+/HER2- patients, was used as validation cohort (cohort 2). Kaplan–Meier estimates and Cox regression univariate/multivariable analyses were performed using breast cancer-specific survival(BCSS) and progression-free interval (PFI) as endpoints in cohorts 1 and 2, respectively. Gene signature scores were calculated using the R genefu package. Likelihood ratio (LR) tests and concordance indices (c-indices) were used to assess each score’s added prognostic value. Results: PD-L1 mRNA expression (treated as a continuous variable) was independently associated with better BCSS in cohort 1 (HR = 0.72; 95% CI = 0.58-0.90;p = 0.003) and with better PFI in cohort 2 (HR = 0.67; 95% CI = 0.50-0.90; p = 0.008) in the multivariable analysis. PD-L1 provided significant additional prognostic information beyond that of both RS alone (LR-Δχ 2 = 9.6; p = 0.002 and LR-Δχ 2 = 9.7; p = 0.002, in cohorts 1 and 2, respectively), and 70-gene signature score alone (LR-Δχ 2 = 10.4; p = 0.001 and LR-Δχ 2 = 9.2; p = 0.002 in cohort 1 and 2, respectively). C-indices for PD-L1 + RS vs RS were 0.65 vs 0.60 (cohort 1) and 0.66 vs 0.60 (cohort 2), and for PD-L1 + 70-gene vs 70-gene were 0.65 vs 0.59 (cohort 1) and 0.64 vs 0.54 (cohort 2), respectively. Conclusions: PD-L1 gene expression was correlated with better outcomes and can provide added prognostic value to RS and 70-gene signature scores in ER+/HER2- BC." @default.
- W2947257837 created "2019-06-07" @default.
- W2947257837 creator A5009958595 @default.
- W2947257837 creator A5019241220 @default.
- W2947257837 creator A5026436902 @default.
- W2947257837 creator A5039948885 @default.
- W2947257837 creator A5062996283 @default.
- W2947257837 creator A5082110835 @default.
- W2947257837 date "2019-05-20" @default.
- W2947257837 modified "2023-09-30" @default.
- W2947257837 title "Prognostic value of PD-L1 gene expression with Recurrence Score and 70-gene signature in patients with ER+/HER2- early breast cancer." @default.
- W2947257837 doi "https://doi.org/10.1200/jco.2019.37.15_suppl.550" @default.
- W2947257837 hasPublicationYear "2019" @default.
- W2947257837 type Work @default.
- W2947257837 sameAs 2947257837 @default.
- W2947257837 citedByCount "0" @default.
- W2947257837 crossrefType "journal-article" @default.
- W2947257837 hasAuthorship W2947257837A5009958595 @default.
- W2947257837 hasAuthorship W2947257837A5019241220 @default.
- W2947257837 hasAuthorship W2947257837A5026436902 @default.
- W2947257837 hasAuthorship W2947257837A5039948885 @default.
- W2947257837 hasAuthorship W2947257837A5062996283 @default.
- W2947257837 hasAuthorship W2947257837A5082110835 @default.
- W2947257837 hasConcept C104317684 @default.
- W2947257837 hasConcept C121608353 @default.
- W2947257837 hasConcept C126322002 @default.
- W2947257837 hasConcept C143998085 @default.
- W2947257837 hasConcept C150194340 @default.
- W2947257837 hasConcept C2779733811 @default.
- W2947257837 hasConcept C2781197716 @default.
- W2947257837 hasConcept C502942594 @default.
- W2947257837 hasConcept C530470458 @default.
- W2947257837 hasConcept C54355233 @default.
- W2947257837 hasConcept C71924100 @default.
- W2947257837 hasConcept C86803240 @default.
- W2947257837 hasConceptScore W2947257837C104317684 @default.
- W2947257837 hasConceptScore W2947257837C121608353 @default.
- W2947257837 hasConceptScore W2947257837C126322002 @default.
- W2947257837 hasConceptScore W2947257837C143998085 @default.
- W2947257837 hasConceptScore W2947257837C150194340 @default.
- W2947257837 hasConceptScore W2947257837C2779733811 @default.
- W2947257837 hasConceptScore W2947257837C2781197716 @default.
- W2947257837 hasConceptScore W2947257837C502942594 @default.
- W2947257837 hasConceptScore W2947257837C530470458 @default.
- W2947257837 hasConceptScore W2947257837C54355233 @default.
- W2947257837 hasConceptScore W2947257837C71924100 @default.
- W2947257837 hasConceptScore W2947257837C86803240 @default.
- W2947257837 hasLocation W29472578371 @default.
- W2947257837 hasOpenAccess W2947257837 @default.
- W2947257837 hasPrimaryLocation W29472578371 @default.
- W2947257837 hasRelatedWork W1083529675 @default.
- W2947257837 hasRelatedWork W2040204671 @default.
- W2947257837 hasRelatedWork W2112790287 @default.
- W2947257837 hasRelatedWork W2322037448 @default.
- W2947257837 hasRelatedWork W2347832250 @default.
- W2947257837 hasRelatedWork W2423934772 @default.
- W2947257837 hasRelatedWork W2556637489 @default.
- W2947257837 hasRelatedWork W2593923945 @default.
- W2947257837 hasRelatedWork W2594450568 @default.
- W2947257837 hasRelatedWork W2605399321 @default.
- W2947257837 hasRelatedWork W2767861873 @default.
- W2947257837 hasRelatedWork W2790027248 @default.
- W2947257837 hasRelatedWork W2792157001 @default.
- W2947257837 hasRelatedWork W2838678364 @default.
- W2947257837 hasRelatedWork W2896077517 @default.
- W2947257837 hasRelatedWork W2938876221 @default.
- W2947257837 hasRelatedWork W2945567362 @default.
- W2947257837 hasRelatedWork W2980393696 @default.
- W2947257837 hasRelatedWork W3111075695 @default.
- W2947257837 hasRelatedWork W3163469023 @default.
- W2947257837 isParatext "false" @default.
- W2947257837 isRetracted "false" @default.
- W2947257837 magId "2947257837" @default.
- W2947257837 workType "article" @default.